GC
ORGO icon

Guggenheim Capital’s Organogenesis Holdings ORGO Stock Holding History

Guggenheim Capital’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-19,946
Closed -$53.7K – 1987
2022
Q4 		$53.7K Sell
19,946
-3,419
-15% -$9.97K ﹤0.01% 1896
2022
Q3 		$75K Sell
23,365
-30,592
-57% -$138K ﹤0.01% 1858
2022
Q2 		$263K Buy
53,957
+27,700
+105% +$171K ﹤0.01% 1837
2022
Q1 		$201K Sell
26,257
-810
-3% -$6.27K ﹤0.01% 2053
2021
Q4 		$250K Buy
+27,067
New +$287K ﹤0.01% 1955

Other funds holding ORGO

SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Guggenheim Capital's ORGO Position: Q1 2023 in Review

Guggenheim Capital sold out of Organogenesis Holdings (ORGO) in Q1 2023, closing a stake of 19,946 shares — an estimated $53.7K sold.

Guggenheim Capital first reported a position in ORGO in Q4 2021 and held it in 5 quarters. The position peaked at $263K in Q2 2022. 131 funds tracked by Wall St. Rank hold ORGO as of Q1 2023.

  • Guggenheim Capital reported no remaining Organogenesis Holdings position as of Q1 2023 after selling out during the quarter.
  • Guggenheim Capital sold 19,946 Organogenesis Holdings shares in Q1 2023, an estimated $53.7K.
  • Guggenheim Capital first reported a position in Organogenesis Holdings in Q4 2021 and held it in 5 quarters.
  • Guggenheim Capital's Organogenesis Holdings position peaked at $263K in Q2 2022.
  • 131 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q1 2023.

Based on Guggenheim Capital's 13F filing for Q1 2023, filed 11 May 2023.